Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJEEC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,169
Award facts
- Contract value 100% obligated
- $21,169.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,169.17 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This non-set-aside, competitively awarded delivery order carries a firm fixed price structure with an ultimate completion date of September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of medications and medical commodities to support military healthcare programs worldwide. This prime indefinite delivery vehicle encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. The Jardiance delivery order represents a routine pharmaceutical procurement under this broader contract framework, consistent with DLA's ongoing efforts to maintain adequate pharmaceutical inventories for military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FJEEC?
SPE2DB25FJEEC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FJEEC worth?
The government has obligated $21,169 on SPE2DB25FJEEC.
Is contract SPE2DB25FJEEC an order under another contract?
Yes. SPE2DB25FJEEC is a delivery order under SPE2DB24D1201, an indefinite delivery contract.
Was contract SPE2DB25FJEEC competed?
The extent of competition for SPE2DB25FJEEC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award